Advancing theranostics with tumor-targeting peptides for precision otolaryngology
Worldwide, about 600,000 head and neck squamous cell carcinoma (HNSCC) are detected annually, many of which involve high risk human papilloma virus (HPV). Surgery is the primary and desired first treatment option. Following surgery, the existence of cancer cells at the surgical margin is strongly as...
| Main Authors: | , , , |
|---|---|
| Format: | Article |
| Language: | English |
| Published: |
KeAi Communications Co., Ltd.
2016-06-01
|
| Series: | World Journal of Otorhinolaryngology-Head and Neck Surgery |
| Online Access: | http://www.sciencedirect.com/science/article/pii/S2095881116300166 |